Phan Quang Tan, Nguyen Hieu Lan, Le Tai Duc, Lee WangSoo, Won HoYoun, Shin SeungYong, Sharmin Saima, Nguyen Truong Quang, Kim SangWook
Intervention Center, Quang Nam Central General Hospital, Quang Nam 562314, Vietnam.
Intervention Center, Chung-Ang University Hospital, Seoul 06973, Korea.
Cardiol Res. 2018 Dec;9(6):385-391. doi: 10.14740/cr776w. Epub 2018 Dec 7.
Even cardiac surgery has been accepted as the standard therapy for Lutembacher syndrome, a combination of congenital ostium secundum atrial septal defect (ASD) and acquired mitral valve stenosis (MVS), it also owns many limitations and disadvantages. Therefore, seeking for a less invasive therapy with the same efficacy may be worthwhile. Thanks to the development in technology and experience gaining in cardiovascular intervention, the combination of the two proved effective procedures, including percutaneous MVS treatment using balloon valvuloplasty and percutaneous ASD closure using atrial septal occluders, can be utilized as an attractive alternative therapy for these conditions. Here, we present a successful percutaneous intervention in Lutembacher syndrome using the combination of mitral balloon valvuloplasty and ASD device closure and thoroughly review the experience of using this combined procedure existing in the literature.
即使心脏手术已被公认为鲁登巴赫综合征(一种先天性继发孔型房间隔缺损(ASD)与后天性二尖瓣狭窄(MVS)的组合)的标准治疗方法,但它也存在许多局限性和缺点。因此,寻求一种疗效相同但侵入性较小的治疗方法可能是值得的。得益于技术的发展和心血管介入经验的积累,事实证明,将两种有效的手术相结合,即使用球囊瓣膜成形术进行经皮MVS治疗和使用房间隔封堵器进行经皮ASD封堵,可以作为这些病症颇具吸引力的替代治疗方法。在此,我们展示了一例使用二尖瓣球囊瓣膜成形术和ASD装置封堵相结合的方法成功治疗鲁登巴赫综合征的经皮介入手术,并全面回顾了文献中使用这种联合手术的经验。